Research and analysis

COVID-19: laboratory evaluations of serological assays

PHE has undertaken a number of rapid evaluations of commercial serological assays for their suitability for detecting the production of COVID-19 antibodies.

From:
Public Health England
Published
19 May 2020
Last updated
26 May 2021 — See all updates

Documents

Evaluation of Roche Elecsys Anti-SARS-CoV-2 S serology assay for the detection of anti-SARS-CoV-2 S antibodies

Ref: PHE publications gateway number: GOV-8331

PDF, 773 KB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of Siemens Atellica-IM IgG (sCOVG) SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 IgG antibodies

PDF, 755 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Supporting information for the PHE commercial serology assay evaluations

Ref: Ref: PHE publications gateway number GW-1489

PDF, 642 KB, 16 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of the Beckman Coulter Access Anti-SARS-CoV-2 IgG assay for the detection of anti-SARS-CoV-2 antibodies

Ref: PHE publications gateway number GW-1469

PDF, 864 KB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Supporting information for the PHE commercial serology assay evaluations

PDF, 647 KB, 16 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of Siemens Atellica-IM Total (COV2T) SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 total antibodies

Ref: PHE publications gateway number GW-1354

PDF, 905 KB, 18 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic Products Anti-SARS-CoV-2 Totalserology assay for the detection of anti-SARS-CoV-2 antibodies

Ref: PHE publications gateway number GW-1354

PDF, 636 KB, 18 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of DiaSorin LIAISON SARS-CoV-2 S1/S2 IgG serology assay for the detection of anti-SARS-CoV-2 antibodies

Ref: PHE publications gateway number GW-1344

PDF, 610 KB, 19 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of the Euroimmun Anti-SARS-CoV-2 ELISA (IgG) serology assay for the detection of anti-SARS-CoV-2 antibodies

Ref: PHE publications gateway number GW-1344

PDF, 768 KB, 18 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of Abbott SARS-CoV-2 IgG for the detection of anti-SARS-CoV-2 antibodies

PDF, 539 KB, 18 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of Roche Elecsys Anti-SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 antibodies

PDF, 649 KB, 17 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic Products Anti-SARS-CoV-2 IgG serology assay for the detection of anti-SARS-CoV-2 antibodies

Ref: PHE publications gateway number GW-1315

PDF, 588 KB, 18 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Please refer to the position statement and conflict of interest statement regarding these evaluations.

Updates to this page

Published 19 May 2020
Last updated 26 May 2021 + show all updates

  1. Added Evaluation of Roche Elecsys Anti-SARS-CoV-2 S serology assay.

  2. Uploaded new version of Supporting information for the PHE commercial serology assay evaluations.

  3. Added Evaluation of Siemens Atellica-IM IgG (sCOVG) SARS-CoV-2 serology assay.

  4. Added Beckman Coulter Access Anti-SARS-CoV-2 IgG assay and supporting information for the PHE commercial serology assay evaluations.

  5. Added 'Evaluation of Siemens Atellica-IM Total (COV2T) SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 total antibodies' and 'Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic Products Anti-SARS-CoV-2 Totalserology assay for the detection of anti-SARS-CoV-2 antibodies'.

  6. Added 'Evaluation of DiaSorin LIAISON SARS-CoV-2 S1/S2 IgG serology assay for the detection of anti-SARS-CoV-2 antibodies' and 'Evaluation of the Euroimmun Anti-SARS-CoV-2 ELISA (IgG) serology assay for the detection of anti-SARS-CoV-2 antibodies'.

  7. Updated Evaluation of Roche Elecsys Anti-SARS-CoV-2 serology assay for the detection of anti-SARS-CoV-2 antibodies.

  8. Updated Evaluation of Abbott SARS-CoV-2 IgG for the detection of anti-SARS-CoV-2 antibodies.

  9. Added Evaluation of the Ortho Clinical Diagnostics Vitros Immunodiagnostic document.

  10. Added updated Abbott and Roche evaluation reports.

  11. Updated reports.

  12. First published.

Sign up for emails or print this page

Related content